Total Payments
$17,257
2024 Payments
$1,758
Companies
64
Transactions
934
Medicare Patients
6,715
Medicare Billing
$711,127
Payment Breakdown by Category
Food & Beverage$17,181 (99.6%)
Education$75.31 (0.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,181 | 930 | 99.6% |
| Education | $75.31 | 4 | 0.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,276 | 145 | $0 (2024) |
| Novo Nordisk Inc | $2,034 | 110 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,734 | 82 | $0 (2024) |
| Amgen Inc. | $1,263 | 65 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,131 | 72 | $0 (2024) |
| Lilly USA, LLC | $1,012 | 62 | $0 (2024) |
| Abbott Laboratories | $675.65 | 17 | $0 (2023) |
| PFIZER INC. | $675.20 | 37 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $672.15 | 44 | $0 (2024) |
| Astellas Pharma US Inc | $630.04 | 26 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,758 | 91 | ABBVIE INC. ($260.46) |
| 2023 | $1,916 | 107 | ABBVIE INC. ($536.49) |
| 2022 | $3,131 | 166 | ABBVIE INC. ($653.03) |
| 2021 | $3,347 | 210 | AbbVie Inc. ($612.55) |
| 2020 | $2,371 | 138 | AstraZeneca Pharmaceuticals LP ($563.63) |
| 2019 | $2,472 | 131 | AstraZeneca Pharmaceuticals LP ($361.43) |
| 2018 | $1,490 | 54 | Janssen Pharmaceuticals, Inc ($263.45) |
| 2017 | $770.29 | 37 | Merck Sharp & Dohme Corporation ($129.75) |
All Payment Transactions
934 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Respiratory | ||||||
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/07/2024 | Takeda Pharmaceuticals U.S.A., Inc. | — | Food and Beverage | In-kind items and services | $44.85 | General |
| 12/02/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: VACCINE | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $28.01 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Biological | ||||||
| 11/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: DIABETES | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $12.53 | General |
| Category: Obesity | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $10.53 | General |
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Respiratory | ||||||
| 10/01/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.21 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.78 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Obesity | ||||||
| 09/23/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.36 | General |
| Category: Diabetes | ||||||
| 09/19/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $9.45 | General |
| Category: NEUROSCIENCE | ||||||
| 09/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.47 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.08 | General |
| Category: Diabetes | ||||||
| 08/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $9.93 | General |
| 08/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: Respiratory | ||||||
| 08/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.18 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: Psychology/Psychiatric | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,307 | 1,661 | $489,646 | $144,323 |
| 2022 | 19 | 1,488 | 1,995 | $481,222 | $166,884 |
| 2021 | 25 | 1,861 | 2,708 | $527,764 | $205,347 |
| 2020 | 29 | 2,059 | 3,017 | $510,584 | $194,573 |
Total Patients
6,715
Total Services
9,381
Medicare Billing
$711,127
Procedure Codes
85
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 551 | 888 | $284,160 | $72,138 | 25.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 402 | 402 | $131,052 | $50,440 | 38.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 40 | 44 | $19,976 | $5,051 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 73 | 80 | $18,240 | $4,324 | 23.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 37 | 37 | $15,651 | $3,719 | 23.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 42 | 42 | $6,888 | $2,949 | 42.8% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 13 | 13 | $5,460 | $2,131 | 39.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 29 | 31 | $2,418 | $1,649 | 68.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 43 | 43 | $3,182 | $1,300 | 40.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 34 | 36 | $900.00 | $334.31 | 37.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 23 | $1,587 | $240.03 | 15.1% |
| 81003 | Automated urinalysis test | Office | 2023 | 20 | 22 | $132.00 | $48.40 | 36.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 535 | 955 | $268,817 | $81,549 | 30.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 384 | 384 | $111,296 | $50,076 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 110 | $22,200 | $6,961 | 31.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 40 | 43 | $17,247 | $5,768 | 33.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $17,076 | $5,451 | 31.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 71 | 71 | $11,644 | $4,798 | 41.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 24 | 24 | $9,145 | $3,865 | 42.3% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 14 | $6,242 | $2,316 | 37.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 73 | 73 | $4,739 | $2,064 | 43.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 15 | 18 | $2,603 | $741.18 | 28.5% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 19 | 19 | $2,822 | $645.24 | 22.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 56 | 61 | $1,255 | $586.22 | 46.7% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 17 | 18 | $2,163 | $550.10 | 25.4% |
About Dr. Peter Jansen, MD
Dr. Peter Jansen, MD is a Family Medicine healthcare provider based in Fleming Island, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689634172.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Jansen, MD has received a total of $17,257 in payments from pharmaceutical and medical device companies, with $1,758 received in 2024. These payments were reported across 934 transactions from 64 companies. The most common payment nature is "Food and Beverage" ($17,181).
As a Medicare-enrolled provider, Jansen has provided services to 6,715 Medicare beneficiaries, totaling 9,381 services with total Medicare billing of $711,127. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Fleming Island, FL
- Active Since 03/27/2006
- Last Updated 09/07/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689634172
Products in Payments
- FARXIGA (Drug) $1,085
- UBRELVY (Drug) $870.34
- VRAYLAR (Drug) $847.79
- TRELEGY ELLIPTA (Drug) $715.22
- JARDIANCE (Drug) $674.45
- EVENITY (Biological) $601.67
- Ozempic (Drug) $575.85
- QULIPTA (Drug) $562.88
- MYRBETRIQ (Drug) $467.12
- TRULICITY (Drug) $429.36
- Rybelsus (Drug) $355.66
- CHANTIX (Drug) $335.46
- Aimovig (Biological) $332.34
- XARELTO (Drug) $325.59
- Vascepa (Drug) $322.48
- RYBELSUS (Drug) $313.64
- NURTEC ODT (Drug) $295.68
- Wegovy (Drug) $275.19
- JANUVIA (Drug) $256.40
- ENTRESTO (Drug) $243.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Fleming Island
Jennifer Sidey, Md, MD
Family Medicine — Payments: $151,583
Family Medicine $151,583
Curtis Storm, M.d, M.D
Family Medicine — Payments: $13,601
Family Medicine $13,601
Dr. Mohammed Mendhi, Md, MD
Family Medicine — Payments: $13,221
Family Medicine $13,221
Dr. Danisha Stevenson, M.d, M.D
Family Medicine — Payments: $9,268
Family Medicine $9,268
Dr. Michael Schriver, Md, MD
Family Medicine — Payments: $7,851
Family Medicine $7,851
William Sessions, M.d, M.D
Family Medicine — Payments: $7,805
Family Medicine $7,805